UroToday.com (@urotoday) / X

UroToday.com

125.5K posts

UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

Reno, NV

Joined February 2009

UroToday.com
@urotoday
Jun 18, 2025
Absolute lymphocyte count and neutrophil-to-lymphocyte ratios: Overlooked biomarkers in cancer treatment outcomes. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss research across multiple tumor types showing that patients maintaining ALC above 1,500 have
8.3K
UroToday.com
@urotoday
Jul 21, 2025
Protecting immune cells before radiation in #ProstateCancer treatment. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss N-803 immunotherapy & its potential to protect immune cells before radiation. #WatchNow for insights into innovative cancer care >
7.8K
UroToday.com
@urotoday
Aug 14, 2025
Protecting immune cells before radiation in #ProstateCancer treatment. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss N-803 immunotherapy & its potential to protect immune cells before radiation. #WatchNow for insights into innovative cancer care >
5.3K
UroToday.com
@urotoday
May 16, 2025
Absolute lymphocyte count and neutrophil-to-lymphocyte ratios: Overlooked biomarkers in cancer treatment outcomes. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss research across multiple tumor types showing that patients maintaining ALC above 1,500 have
5.7K
UroToday.com
@urotoday
May 16, 2025
Papillary non-muscle invasive #BladderCancer treatment guidelines gap. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss expanding ANKTIVA® (NAI) use to include papillary-only BCG-unresponsive bladder cancer. 📊 82% bladder preservation at 36 months 🧬
6.9K
UroToday.com
@urotoday
Aug 19, 2025
Absolute lymphocyte count and neutrophil-to-lymphocyte ratios: Overlooked biomarkers in cancer treatment outcomes. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss research across multiple tumor types showing that patients maintaining ALC above 1,500 have
5.9K
UroToday.com
@urotoday
Jun 23, 2025
Recombinant BCG addressing #BladderCancer treatment shortages. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss efforts to address BCG shortage with "supercharged" recombinant BCG, showing unprecedented efficacy & less toxicity. The FDA expanded access
4.9K
UroToday.com
@urotoday
Aug 10, 2025
Papillary non-muscle invasive #BladderCancer treatment guidelines gap. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss expanding ANKTIVA® (NAI) use to include papillary-only BCG-unresponsive bladder cancer. 📊 82% bladder preservation at 36 months 🧬
5.7K
UroToday.com
@urotoday
Jun 15, 2025
Papillary non-muscle invasive #BladderCancer treatment guidelines gap. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonnews to discuss expanding ANKTIVA® (NAI) use to include papillary-only BCG-unresponsive bladder cancer. 📊 82% bladder preservation at 36 months 🧬
5.3K
UroToday.com
@urotoday
Jun 26, 2025
Protecting immune cells before radiation in #ProstateCancer treatment. @drpatrick @ImmunityBio and @UroDocAsh @MDAndersonNews discuss N-803 immunotherapy & its potential to protect immune cells before radiation. #WatchNow for insights into innovative cancer care >
5.4K
UroToday.com
@urotoday
Feb 13, 2025
Radical prostatectomy vs radiotherapy in high-risk #ProstateCancer: Emulated randomized comparison with individual patient data from two phase III randomized trials. - A new emulated RCT analysis finds that radiotherapy + long-term ADT results in lower distant metastasis rates
11K
UroToday.com
@urotoday
Aug 18, 2025
Recombinant BCG addressing #BladderCancer treatment shortages. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss efforts to address BCG shortage with "supercharged" recombinant BCG, showing unprecedented efficacy & less toxicity. The FDA expanded access
5.9K
UroToday.com
@urotoday
Sep 15, 2025
Recombinant BCG addressing #BladderCancer treatment shortages. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss efforts to address BCG shortage with "supercharged" recombinant BCG, showing unprecedented efficacy & less toxicity. The FDA expanded access
5.9K
UroToday.com
@urotoday
Jul 21, 2025
Recombinant BCG addressing #BladderCancer treatment shortages. @drpatrick @ImmunityBio joins @UroDocAsh @MDAndersonNews to discuss efforts to address BCG shortage with "supercharged" recombinant BCG, showing unprecedented efficacy & less toxicity. The FDA expanded access
4.8K